Conclusioni e suggerimenti● La dimensione del dolore più comunemente misurata in ambito clinico e dellaricerca è l’intensità del dolore.● A tale fine possono essere ut<strong>il</strong>izzate scale unidimensionali tra le quali quella attualmenteut<strong>il</strong>izzata con più frequenza è la NRS da 0 a 10.● In specifici casi può essere ut<strong>il</strong>e misurare altre dimensioni del dolore, come lecaratteristiche temporali, l’interferenza con l’attività fisica, gli stati d’animo, <strong>il</strong>sonno, la qualità di vita… e altre ancora.● In queste situazioni possono essere usati strumenti di misurazione specifici o questionaridi valutazione multidimensionali.● Tra questi ultimi strumenti quello attualmente più ut<strong>il</strong>izzato è <strong>il</strong> Brief Pain Inventory(BPI).● La valutazione della percezione di efficacia e della soddisfazione del pazienteper i trattamenti antalgici ricevuti può apportare un aiuto complementare alleinformazioni ottenute con gli strumenti indicati in precedenza.Bibliografia1. Kaasa S. et al: Consensus expert conference on cancer pain assessment and classification: the needfor international standards. IN PREPARAZIONE.2. Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L, De Conno F: Pain measurementtools and methods in clinical research in palliative care: recommendations of an Expert WorkingGroup of the European Association of Palliative Care. J Pain Symptom Manage 2002, 23(3):239-255.3. Holen JC, Hjermstad MJ, Loge JH, Fayers PM, Caraceni A, De Conno F, Forbes K, Furst CJ, RadbruchL, Kaasa S: Pain assessment tools: is the content appropriate for use in palliative care? J PainSymptom Manage 2006, 32(6):567-580.4. Hjermstad MJ, Gibbins J, Haugen DF, Caraceni A, Loge JH, Kaasa S, EPCRC, European PalliativeCare Research Collaborative: Pain assessment tools in palliative care: an urgent need for consensus.Palliat Med 2008, 22(8):895-903.5. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G,Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, KramerLD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, RappaportBA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, WernickeJ, Witter J, IMMPACT: Core outcome measures for chronic pain clinical trials: IMMPACTrecommendations. Pain 2005, 113(1-2):9-19.6. (http://www.aiom.it)7. Jensen MP: The validity and reliab<strong>il</strong>ity of pain measures in adults with cancer. J Pain 2003, 4(1):2-21.8. Caraceni A, Zecca E, Martini C, Brunelli C, Pigni A, Gorni G, Galbiati A, Ibazeta M, HjermstadM, Kaasa S: The validity of average 8-h pain intensity assessment in cancer patients. Eur J Pain2009.21
MISURAZIONE DEL DOLORE ONCOLOGICO229. Jensen MP, McFarland CA: Increasing the reliab<strong>il</strong>ity and validity of pain intensity measurementin chronic pain patients. Pain 1993, 55(2):195-203.10. Mercadante S, Radbruch L, Caraceni A, Cherny N, Kaasa S, Nauck F, Ripamonti C, De Conno F,Steering Committee of the European Association for Palliative Care (EAPC) Research Network: Episodic(breakthrough) pain: consensus conference of an expert working group of the European Associationfor Palliative Care. Cancer 2002, 94(3):832-839.11. Hagen NA, St<strong>il</strong>es C, Nekolaichuk C, Biondo P, Carlson LE, Fisher K, Fainsinger R: The Alberta BreakthroughPain Assessment Tool for cancer patients: a validation study using a delphi process andpatient think-aloud interviews. J Pain Symptom Manage 2008, 35(2):136-152.12. Haugen DF, Hjermstad MJ, Hagen N, Caraceni A, Kaasa S: Assessment and classification of cancerbreakthrough pain. A systematic literature review. ACCEPTED FOR PUBLICATION. Pain .13. Portenoy RK, Payne D, Jacobsen P: Breakthrough pain: characteristics and impact in patients withcancer pain. Pain 1999, 81(1-2):129-134.14. Jensen MP, Karoly P, Braver S: The measurement of clinical pain intensity: a comparison of sixmethods. Pain 1986, 27(1):117-126.15. De Conno F, Caraceni A, Gamba A, Mariani L, Abbattista A, Brunelli C, La Mura A, VentafriddaV: Pain measurement in cancer patients: a comparison of six methods. Pain 1994, 57(2):161-166.16. Brunelli C, Zecca E, Martini C, Campa T, Fagnoni E, Bagnasco M, Lanata L, Caraceni A: Comparisonof numerical and verbal rating scales to measure pain exacerbations in patients with chroniccancer pain. INVIATO PER PUBBLICAZIONE. HQLO 2010, .17. Price DD, Bush FM, Long S, Harkins SW: A comparison of pain measurement characteristics ofmechanical visual analogue and simple numerical rating scales. Pain 1994, 56(2):217-226.18. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS: When is cancer pain m<strong>il</strong>d, moderateor severe? Grading pain severity by its interference with function. Pain 1995, 61(2):277-284.19. Jensen MP, Chen C, Brugger AM: Postsurgical pain outcome assessment. Pain 2002, 99(1-2):101-109.20. Houde RW, Wallenstein SL, Beaver WT: Clinical measurement of pain. In Analgesics. Edited byde Stevens G. New York: Academic Press; 1965:75-122.21. Feine JS, Lavigne GJ, Dao TT, Morin C, Lund JP: Memories of chronic pain and perceptions of relief.Pain 1998, 77(2):137-141.22. Melzack R: The McG<strong>il</strong>l Pain Questionnaire: major properties and scoring methods. Pain 1975,1(3):277-299.23. Melzack R: The short-form McG<strong>il</strong>l Pain Questionnaire. Pain 1987, 30(2):191-197.24. Maiani G, Sanavio E: Semantics of pain in Italy: the Italian version of the McG<strong>il</strong>l Pain Questionnaire.Pain 1985, 22(4):399-405.25. De Benedittis G, Massei R, Nob<strong>il</strong>i R, Pieri A: The Italian Pain Questionnaire. Pain 1988, 33(1):53-62.26. De Conno F, Caraceni A, Gamba A, Mariani L, Abbattista A, Brunelli C, La Mura A, VentafriddaV: Pain measurement in cancer patients: a comparison of six methods. Pain 1994, 57(2):161-166.27. Caraceni A, Mendoza TR, Mencaglia E, Baratella C, Edwards K, Forjaz MJ, Martini C, Serlin RC,de Conno F, Cleeland CS: A validation study of an Italian version of the Brief Pain Inventory (BreveQuestionario per la Valutazione del Dolore). Pain 1996, 65(1):87-92.28. Anonymous Quality improvement guidelines for the treatment of acute pain and cancer pain. AmericanPain Society Quality of Care Committee. JAMA 1995, 274(23):1874-1880.29. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R,Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, Mc-Dermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW,Stein W, Tollett J, Witter J: Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.Pain 2003, 106(3):337-345.30. Lipton R, Stewart W: Acute migraine therapy: do doctors understand what patients with migraine